Phase I/II study of tecemotide cancer immunotherapy for Japanese patients with unresectable stage III non-small cell lung cancer (NSCLC).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 3036-3036 ◽  
Author(s):  
Hiroshi Nokihara ◽  
Nobuyuki Katakami ◽  
Toyoaki Hida ◽  
Fumio Imamura ◽  
Hiroshi Sakai ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cancer Immunotherapy ◽  
Cell Lung Cancer ◽  
Japanese Patients ◽  
Small Cell ◽  
Stage Iii ◽  
Small Cell Lung ◽  
Unresectable Stage

Phase I/II study of tecemotide as immunotherapy in Japanese patients with unresectable stage III non-small cell lung cancer

Lung Cancer ◽  
2017 ◽  
Vol 105 ◽  
pp. 23-30 ◽  
Author(s):  
Nobuyuki Katakami ◽  
Toyoaki Hida ◽  
Hiroshi Nokihara ◽  
Fumio Imamura ◽  
Hiroshi Sakai ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Japanese Patients ◽  
Small Cell ◽  
Stage Iii ◽  
Small Cell Lung ◽  
Unresectable Stage

Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer

2004 ◽  
Vol 95 (8) ◽  
pp. 691-695 ◽  
Author(s):  
Ikuo Sekine ◽  
Kazumasa Noda ◽  
Fumihiro Oshita ◽  
Kouzou Yamada ◽  
Manabu Tanaka ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Stage Iii ◽  
Thoracic Radiotherapy ◽  
Small Cell Lung ◽  
Unresectable Stage
Sign in / Sign up

Export Citation Format

Share Document